Product
Zofin
3 clinical trials
5 indications
Indication
Chronic Obstructive Pulmonary DiseaseIndication
COVID-19Indication
Coronavirus InfectionIndication
Severe Acute Respiratory Syndrome (SARS)Indication
Acute Respiratory Distress SyndromeClinical trial
A Phase I/II Randomized, Double Blinded, Placebo Trial to Evaluate the Safety and Potential Efficacy of Intravenous Infusion (IV) of ZofinTM for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)Status: , Estimated PCD: 2024-05-30
Clinical trial
A Phase I/II Randomized, Double Blinded, Placebo Trial to Evaluate the Safety and Potential Efficacy of Intravenous Infusion of Zofin for the Treatment of Moderate to SARS Related to COVID-19 Infection vs PlaceboStatus: Completed, Estimated PCD: 2023-07-01
Clinical trial
A Phase I/II Multicenter, Randomized, Double Blinded, Placebo Trial to Evaluate the Safety and Potential Efficacy of Zofin Infused Intravenous (IV) in Patients Experiencing Prolonged COVID-19 Symptoms (Long-Haulers) vs Placebo.Status: Completed, Estimated PCD: 2023-10-01